Fig. 80 (abstract O60).From: International Society for Therapeutic Ultrasound Conference 2016BH lesion produced in ex vivo human clear cell renal carcinoma (left) and benign human kidney cortex (right) with two different BH doses (10 and 30 pulses, respectively) are similar in size, demonstrating increased tumour tissue susceptibility to BH-induced damage compared to benign tissueBack to article page